Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics

Azzdine Y. Ammi, Jonathan R. Lindner, Yan Zhao, Thomas Richard Porter, Robert Siegel, Sanjiv Kaul

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×107 ml-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.

Original languageEnglish (US)
Pages (from-to)1357-1369
Number of pages13
JournalThrombosis and Haemostasis
Volume113
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Acoustics
Pressure
Ultrasonography
Thrombosis
Fluorocarbons
Microbubbles
Contrast Media
Blood Vessels
Swine
Clinical Trials
Lipids
Therapeutics

Keywords

  • Imaging
  • Thrombolysis/thrombolytic agents
  • Ultrasound analysis

ASJC Scopus subject areas

  • Hematology

Cite this

Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics. / Ammi, Azzdine Y.; Lindner, Jonathan R.; Zhao, Yan; Porter, Thomas Richard; Siegel, Robert; Kaul, Sanjiv.

In: Thrombosis and Haemostasis, Vol. 113, No. 6, 01.01.2015, p. 1357-1369.

Research output: Contribution to journalArticle

Ammi, Azzdine Y. ; Lindner, Jonathan R. ; Zhao, Yan ; Porter, Thomas Richard ; Siegel, Robert ; Kaul, Sanjiv. / Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics. In: Thrombosis and Haemostasis. 2015 ; Vol. 113, No. 6. pp. 1357-1369.
@article{973579410d1d4941bc296c7ff3c3648b,
title = "Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics",
abstract = "Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×107 ml-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.",
keywords = "Imaging, Thrombolysis/thrombolytic agents, Ultrasound analysis",
author = "Ammi, {Azzdine Y.} and Lindner, {Jonathan R.} and Yan Zhao and Porter, {Thomas Richard} and Robert Siegel and Sanjiv Kaul",
year = "2015",
month = "1",
day = "1",
doi = "10.1160/TH14-03-0286",
language = "English (US)",
volume = "113",
pages = "1357--1369",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "6",

}

TY - JOUR

T1 - Efficacy and spatial distribution of ultrasound-mediated clot lysis in the absence of thrombolytics

AU - Ammi, Azzdine Y.

AU - Lindner, Jonathan R.

AU - Zhao, Yan

AU - Porter, Thomas Richard

AU - Siegel, Robert

AU - Kaul, Sanjiv

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×107 ml-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.

AB - Ultrasound and microbubble (MB) contrast agents accelerate clot lysis, yet clinical trials have been performed without defining optimal acoustic conditions. Our aim was to assess the effect of acoustic pressure and frequency on the extent and spatial location of clot lysis. Clots from porcine blood were created with a 2-mm central lumen for infusion of lipid-shelled perfluorocarbon MBs (1×107 ml-1) or saline. Therapeutic ultrasound at 0.04, 0.25, 1.05, or 2.00 MHz was delivered at a wide range of peak rarefactional acoustic pressure amplitudes (PRAPAs). Ultrasound was administered over 20 minutes grouped on-off cycles to allow replenishment of MBs. The region of lysis was quantified using contrast-enhanced ultrasound imaging. In the absence of MBs, sonothrombolysis did not occur at any frequency. Sonothrombolysis was also absent in the presence of MBs despite their destruction at 0.04 and 2.00 MHz. It occurred at 0.25 and 1.05 MHz in the presence of MBs for PRAPAs > 1.2 MPa and increased with PRAPA. At 0.25 MHz the clot lysis was located in the far wall. At 1.05 MHz, however, there was a transition from far to near wall as PRAPA was increased. The area of clot lysis measured by ultrasound imaging correlated with that by micro-CT and quantification of debris in the effluent. In conclusion, sonothrombolysis with MBs was most efficient at 0.25 MHz. The spatial location of sonothrombolysis varies with pressure and frequency indicating that the geometric relation between therapeutic probe and vascular thrombosis is an important variable for successful lysis clinically.

KW - Imaging

KW - Thrombolysis/thrombolytic agents

KW - Ultrasound analysis

UR - http://www.scopus.com/inward/record.url?scp=84931275086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931275086&partnerID=8YFLogxK

U2 - 10.1160/TH14-03-0286

DO - 10.1160/TH14-03-0286

M3 - Article

C2 - 25809056

AN - SCOPUS:84931275086

VL - 113

SP - 1357

EP - 1369

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 6

ER -